UNSPSC 85632247: Alteration of bilateral breast with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of bilateral breast with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0H0V37Z

UNSPSC 85632247 Alteration of bilateral breast with autologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent activity in state and local procurement. The six state and local opportunities posted between July and September 2026 under this code—including independent medical evaluation services, surgical benefit administration, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing—bear no connection to breast reconstruction surgery or autologous tissue procedures. The misalignment between the code's clinical specificity and the actual work being solicited suggests either a data-tagging error in the opportunities or that this particular surgical procedure does not drive state and local contracting activity at present. No evidence of relevant contracting demand under this code is present in the recent opportunities block.

This code warrants monitoring rather than pursuit at this time. State and local procurement offices may use higher-tier codes (Family or Class level) within surgical services for broader facility or staffing contracts, but the Commodity code itself shows no pattern of actual state or local government buying for this specific procedure type. Business development professionals should verify whether their firm's service scope aligns with the abstract code definition or the actual demand signals present in the opportunities—in this case, the two do not overlap.